1	 H. R. Smith, "Depression in cancer patients: pathogenesis, implications and treatment (Review)," Oncol Lett, vol. 9, no. 4, pp. 1509-1514, 2015.
2	 Y.-H. Wang et al., "Depression and anxiety in relation to cancer incidence and mortality: A systematic review and meta-analysis of cohort studies," Mol. Psychiatry, vol. 25, pp. 1487-1499, 2020.
6	 B. Obispo, P. P., C. Castellanos, P. Jiménez, and F. Jacobo, "Anxiety and depression in patients with advanced cancer during the COVID-19 pandemic," Support. Care Cancer, vol. 30, pp. 3363-3370, 2022.
7	 A. Kagee, R. Roomaney, and N. Knoll, "Psychosocial predictors of distress and depression among South African breast cancer patients," Psychooncology, vol. 27, pp. 908-914, 2018.
9	 P. Fitzgerald, C. Lo, M. Li, L. Gagliese, C. Zimmermann, and G. Rodin, "The relationship between depression and physical symptom burden in advanced cancer," BMJ Support. Palliat. Care, vol. 5, pp. 381-388, 2015.
10	 D. L. Rosenstein, "Depression and end-of-life care for patients with cancer," Dialogues Clin. Neurosci., vol. 13, pp. 101-108, 2011.
11	 D. Fujisawa, J.S. Temel, L. Traeger, J.A. Greer, I.T. Lennes, M. Mimura, et al., "Psychological factors at early stage of treatment as predictors of receiving chemotherapy at the end of life," Psychooncology, vol. 24, pp. 1731-1737, 2015.
12	 A. Vyas, Z. Babcock, and S. Kogut, "Impact of depression treatment on health-related quality of life among adults with cancer and depression: A population-level analysis," J. Cancer Surviv., vol. 11, pp. 624-633, 2017.
14	 J. Ferlay, M. Colombet, I. Soerjomataram, C. Mathers, D. Parkin, M. Piñeros, et al., "Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods," Int. J. Cancer, vol. 144, no. 8, pp. 1941-1953, 2019.
18	 J.S. Hong and J. Tian, "Prevalence of anxiety and depression and their risk factors in Chinese cancer patients," Support Care Cancer, vol. 22, no. 2, pp. 453-459, 2014.
19	 J. Cho, K. Smith, E.K. Choi, I.R. Kim, Y.J. Chang, H.Y. Park, et al., "Public attitudes toward cancer and cancer patients: A national survey in Korea," Psychooncology, vol. 22, pp. 605-613, 2013.
20	 C.G. Brown Johnson, J.L. Brodsky, and J.K. Cataldo, "Lung cancer stigma, anxiety, depression, and quality of life," J Psychosoc Oncol, vol. 32, pp. 59-73, 2014.
21	 J.K. Cataldo, T.M. Jahan, and V.L. Pongquan, "Lung cancer stigma, depression, and quality of life among ever and never smokers," Eur. J. Oncol. Nurs., vol. 16, pp. 264-269, 2012.
22	 S. Bhattacharyya, S. Bhattacherjee, T. Mandal, and D.K. Das, "Depression in cancer patients undergoing chemotherapy in a tertiary care hospital of North Bengal, India," Indian J Public Health, vol. 61, pp. 14-18, 2017.
24	 W. Rhondali et al., "Frequency of depression among oncology outpatients and association with other symptoms," Support Care Cancer, vol. 20, pp. 2795-2802, 2012.
25	 O. Arrieta, L.P. Angulo, C. Núñez-Valencia, Y. Dorantes-Gallareta, E.O. Macedo, D. Martinez-Lopez, et al., "Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer," Ann. Surg. Oncol., vol. 20, pp. 1941-1948, 2013.
26	 Institute of Health Metrics and Evaluation, "Global Health Data Exchange (GHDx)," [Online]. Available: https://vizhub.healthdata.org/gbd-results/.
33	 M. Colleoni, M. Mandala, G. Peruzzotti, et al., "Depression and degree of acceptance of adjuvant cytotoxic drugs," Lancet, vol. 356, pp. 1326-1327, 2000.
34	 M. Pinquart and P. R. Duberstein, "Depression and cancer mortality: a meta-analysis," Psychol Med, vol. 40, pp. 1797-1810, 2010.
35	 J. R. Satin, W. Linden, and M. J. Phillips, "Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis," Cancer, vol. 115, pp. 5349-5361, 2009.
37	 E. Arvanitou, M. Nikoloudi, N. Tsoukalas, E. Parpa, and K. Mystakidou, "Factors associated with anxiety and depression in cancer patients: Demographic factors and the role of demoralization and satisfaction with care," Psychooncology, vol. 32, no. 5, pp. 712-720, May 2023. [Online]. Available: doi: 10.1002/pon.6115. PMID: 36797821.
38	 P. Fayers, N. Aaronson, K. Bjordal, and M. Groenvold, "EORTC QLQ-C30 Scoring Manual, 3rd ed.," European Organisation for Research and Treatment of Cancer, Brussels, Belgium, 2001.
40	 M.G. De Tejada, A. Bilbao, M. Baré, E. Briones, C. Sarasqueta, J.M. Quintana, et al., "Association of social support, functional status, and psychological variables with changes in health-related quality of life outcomes in patients with colorectal cancer," Psycho-Oncology, vol. 25, pp. 891-897, 2016.
41	 D.E. Lage, A. El-Jawahri, C.-X. Fuh, R.A. Newcomb, V.A. Jackson, D.P. Ryan, et al., "Functional Impairment, Symptom Burden, and Clinical Outcomes among Hospitalized Patients with Advanced Cancer," J. Natl. Compr. Cancer Netw., vol. 18, pp. 747-754, 2020.
42	 D. L. van Abbema et al., "Patient- and tumour-related predictors of chemotherapy intolerance in older patients with cancer: A systematic review," J. Geriatr. Oncol., vol. 10, pp. 31-41, 2019.
44	 J. L. Petrick et al., "Functional status declines among cancer survivors: Trajectory and contributing factors," J. Geriatr. Oncol., vol. 5, pp. 359-367, 2014.
45	 Y. Li, Y. Yang, R. Zhang, K. Yao, and Z. Liu, "The Mediating Role of Mental Adjustment in the Relationship between Perceived Stress and Depressive Symptoms in Hematological Cancer Patients: A Cross-Sectional Study," PLoS ONE, vol. 10, p. e0142913, 2015.
47	 J. Rehm and K. D. Shield, "Global Burden of Disease and the Impact of Mental and Addictive Disorders," Curr. Psychiatry Rep., vol. 21, no. 10, 2019.
48	 F. Jacobi, M. Höfler, J. Siegert, S. Mack, A. Gerschler, L. Scholl, et al., "Twelvemonth prevalence, comorbidity and correlates of mental disorders in Germany: The Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1-MH)," Int. J. Methods Psychiatr. Res., vol. 23, pp. 304-319, 2014.
49	 G. Thornicroft et al., "Undertreatment of people with major depressive disorder in 21 countries," Br. J. Psychiatry, vol. 210, pp. 119-124, 2017.
57	 S. Dolbeault, S. Cayrou, A. Bredart, A. Viala, B. Desclaux, P. Saltel, et al., "The effectiveness of a psycho-educational group after early-stage breast cancer treatment: Results of a randomized French study," Psychooncology, vol. 18, no. 6, pp. 647-656, 2009.
58	 O. Nakash, I. Levav, S. Aguilar-Gaxiola, J. Alonso, L.H. Andrade, M.C. Angermeyer, et al., "Comorbidity of common mental disorders with cancer and their treatment gap: findings from the World Mental Health Surveys," Psychooncology, vol. 23, no. 1, pp. 40-51, 2014.
62	 D. Spiegel, "Cancer and depression," Br J Psychiatry, vol. 168, no. S30, pp. 109-116, 1996.
63	 L.F. Brown, K. Kroenke, D.E. Theobald, J. Wu, and W. Tu, "The association of depression and anxiety with health-related quality of life in cancer patients with depression and/or pain," Psychooncology, vol. 19, no. 7, pp. 734-741, 2010.
64	 F.C. Atesci, B. Baltalarli, N.K. Oguzhanoglu, F. Karadag, O. Ozdel, and N. Karagoz, "Psychiatric morbidity among cancer patients and awareness of illness," Support Care Cancer, vol. 12, no. 3, pp. 161-167, 2004.
65	 W. K. So et al., "Anxiety, depression and quality of life among Chinese breast cancer patients during adjuvant therapy," Eur J Oncol Nurs, vol. 14, no. 1, pp. 17-22, 2010.
67	 J. Lemon, S. Edelman, and A.D. Kidman, "Perceptions of the 'Mind-Cancer' relationship among the public, cancer patients, and oncologists," J. Psychosoc. Oncol., vol. 21, no. 4, pp. 43-58, 2004.
68	 K.M. Brintzenhofe-Szoc, T.T. Levin, Y. Li, D.W. Kissane, and J.R. Zabora, "Mixed anxiety/depression symptoms in a large cancer cohort: prevalence by cancer type," Psychosomatics, vol. 50, no. 4, pp. 383-391, 2009.
69	 K. Sneeuw et al., Eds., "Prevalence and screening of psychiatric disorder in patients with early-stage breast cancer," Quality of Life Research, Rapid Science Publishers, London, England, 1993, pp. 2-6.
70	 M. Okamura, S. Yamawaki, T. Akechi, K. Taniguchi, and Y. Uchitomi, "Psychiatric disorders following first breast cancer recurrence: prevalence, associated factors and relationship to quality of life," Jpn J Clin Oncol, vol. 35, no. 6, pp. 302-309, 2005.
71	 A. Ciaramella and P. Poli, "Assessment of depression among cancer patients: The role of pain, cancer type and treatment," Psychooncology, vol. 10, no. 2, pp. 156-165, 2001.
72	 N. Mhaidat, K. Alzoubi, S. Al-Sweedan, and B. Alhusein, "Prevalence of depression among cancer patients in Jordan: a national survey," Support Care Cancer, vol. 17, no. 11, pp. 1403, 2009.
73	 P.M. Khue, V.T. Thom, D.Q. Minh, L.M. Quang, and N.L. Hoa, "Depression and anxiety as key factors associated with quality of life among lung cancer patients in Hai Phong, Vietnam," Front Psychiatry, vol. 10, p. 352, 2019.
74	 C.Y. Lin, A.S. Cheng, V. Imani, M. Saffari, M.M. Ohayon, and A.H. Pakpour, "Advanced psychometric testing on a clinical screening tool to evaluate insomnia: Sleep condition indicator in patients with advanced cancer," Sleep Biol. Rhythms, vol. 18, pp. 343-349, 2020.
75	 P. Isfahani, M. Arefy, and M. Shamsaii, "Prevalence of severe depression in Iranian women with breast cancer: A meta-analysis," Depress Res Treat, vol. 2020, 2020.
76	 M. Kouhestani, H.A. Gharaei, M. Fararouei, H. Hosienpour Ghahremanloo, and R. Ghaiasvand, "Global and regional geographical prevalence of depression in gastric cancer: A systematic review and meta-analysis," BMJ Support Palliat Care, 2020.
77	 E. Villoria and L. Lara, "Assessment of the hospital anxiety and depression scale for cancer patients," Rev Med Chil, vol. 146, pp. 300-307, 2018.
78	 F. Milligan, F. Martinez, S.H. Aal, S.A. Ahmed, B. Joby, J.S. Matalam, et al., "Assessing anxiety and depression in cancer patients," Br. J. Nurs., vol. 27, pp. S18-S23, 2018.
79	 R.T. Morin and E. Midlarsky, "Depressive symptoms and cognitive functioning among older adults with cancer," Ageing Ment. Health, vol. 22, pp. 1465-1470, 2018.
80	 H. Muneer, F. Altaf, and W. Anwar, "Depression in cancer patients of Punjab," Pak. J. Med. Health Sci., vol. 12, pp. 523-525, 2018.
81	 A. Rodríguez-González et al., "Mental Adjustment, Functional Status, and Depression in Advanced Cancer Patients," International Journal of Environmental Research and Public Health, vol. 20, no. 4, p. 3015, 2023.
82	 D. Riedl and G. Schüßler, "Factors associated with and risk factors for depression in cancer patients—A systematic literature review."
84	 A.J. Mitchell, M. Chan, H. Bhatti, M. Halton, L. Grassi, C. Johansen, N. Meader, "Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies," Lancet Oncol., vol. 12, no. 2, pp. 160-174, 2011.
85	 D. Riedl and G. Schüssler, "Prevalence of depression and cancer - a systematic review," Z. Psychosom. Med. Psychother., vol. 67, 2021. [Online]. Available: https://doi.org/10.13109/zptm.2021.67.Oa11.
86	 R. Tamagawa et al., "Who benefits from psychosocial interventions in oncology? A systematic review of psychological moderators of treatment outcome," J Behav Med, vol. 35, pp. 658-673, 2012.
87	 C.L. Niedzwiedz, L. Knifton, K.A. Robb, S.V. Katikireddi, and D.J. Smith, "Depression and anxiety among people living with and beyond cancer: A growing clinical and research priority," BMC Cancer, vol. 19, p. 943, 2019.
88	 WHO, "Depressive disorder (depression)," [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/depression
